Jazz Pharmaceuticals acquires Redx’s KRAS inhibitor program
Alderley Park, UK: Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz will acquire Redx’s KRAS (Kirsten rat sarcoma...
Redx Pharma appoints leading oncology drug developer, Dr Jane Robertson, as Chief Medical Officer
ALDERLEY PARK: Redx Pharma plc has appointed Dr Jane Robertson as Chief Medical Officer, a news release noted. Jane is a well respected UK haemato-oncologist...